Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Astemizole Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2021 2 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 40 46
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 61 5
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Apr/16/2021 24 7
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/10/2021 35 4
Clofazimine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 4 0
Tetrandrine Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021 4 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/07/2021 7 1
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15